Literature DB >> 12972026

Myb protein specificity: evidence of a context-specific transcription factor code.

Scott A Ness1.   

Abstract

Vertebrates express three different Myb family transcription factors, A-Myb, B-Myb, and c-Myb, that share a highly conserved DNA binding domain, bind to the same DNA sequences, and activate the same reporter gene constructs in transfection assays. However, the three Myb proteins have completely different biological roles, and microarray assays have shown that ectopic expression of each protein causes the activation of different sets of human genes. Furthermore, the genes that are activated by each protein in different cell types are distinct, suggesting that Myb transcription factors are subject to context-specific regulatory mechanisms. The data support a modification code model in which Myb proteins become decorated with different sets of posttranslational modifications in different cell types, and these modifications control the ability of the Myb proteins to interact with other cellular components that are required for activating specific sets of genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972026     DOI: 10.1016/s1079-9796(03)00151-7

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  28 in total

Review 1.  Stem cell pluripotency: a cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle.

Authors:  Kenneth R Boheler
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

2.  c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression.

Authors:  Yuji Nakata; Susan Shetzline; Chizuko Sakashita; Anna Kalota; Ravikumar Rallapalli; Stephen I Rudnick; Yi Zhang; Stephen G Emerson; Alan M Gewirtz
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

3.  Induction of transcription factor A-myb expression in reactive astrocytes following an excitotoxic lesion in the mouse hippocampus.

Authors:  Gye Sun Jeon; Hee Jine Byun; Sung Kyung Park; Sang Wook Park; Dong Woon Kim; Je Hoon Seo; Choong Ik Cha; Sa Sun Cho
Journal:  Neurochem Res       Date:  2006-10-20       Impact factor: 3.996

4.  Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53.

Authors:  Chad Deisenroth; Aaron R Thorner; Takeharu Enomoto; Charles M Perou; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

Review 5.  B-Myb, cancer, senescence, and microRNAs.

Authors:  Ivan Martinez; Daniel Dimaio
Journal:  Cancer Res       Date:  2011-08-09       Impact factor: 12.701

6.  Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1.

Authors:  Wanli Lei; Fan Liu; Scott A Ness
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

7.  Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α.

Authors:  Fumihiko Okumura; Keiji Uematsu; Stuart D Byrne; Mie Hirano; Akiko Joo-Okumura; Akihiko Nishikimi; Taro Shuin; Yoshinori Fukui; Kunio Nakatsukasa; Takumi Kamura
Journal:  Mol Cell Biol       Date:  2016-05-31       Impact factor: 4.272

8.  Loss of androgen receptor in aging and oxidative stress through Myb protooncoprotein-regulated reciprocal chromatin dynamics of p53 and poly(ADP-ribose) polymerase PARP-1.

Authors:  Liheng Shi; Soyoung Ko; Soyoung Kim; Ibtissam Echchgadda; Tae-Sung Oh; Chung S Song; Bandana Chatterjee
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

9.  In vitro and in vivo analysis of B-Myb in basal-like breast cancer.

Authors:  A R Thorner; K A Hoadley; J S Parker; S Winkel; R C Millikan; C M Perou
Journal:  Oncogene       Date:  2008-12-01       Impact factor: 9.867

10.  RFX2 is a candidate downstream amplifier of A-MYB regulation in mouse spermatogenesis.

Authors:  Gary C Horvath; Malathi K Kistler; W Stephen Kistler
Journal:  BMC Dev Biol       Date:  2009-12-09       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.